Table 2 Association between SEC14L1 protein expression and the clinicopathological factors

From: Saccharomyces cerevisiae-like 1 (SEC14L1) is a prognostic factor in breast cancer associated with lymphovascular invasion

Factors

 

Expression of SEC14L1

  

Low

High

Total

p-Value

Tumor size

 ≥ 2 cm

68 (68.7%)

31 (31.3%)

99

0.75

 < 2 cm

49 (71.0%)

20 (29.0%)

69

Nodal status

Positive

55 (67.1%)

27 (32.9%)

82

0.48

Negative

62 (72.1%)

24 (27.9%)

86

Histological grade

Grade 3

53 (60.9%)

34 (39.1%)

87

0.011

Grade 1, 2

64 (79.0%)

17 (21.0%)

81

Lymphovascular invasion

Positive

43 (51.8%)

40 (48.2%)

83

 < 0.0001

Negative

74 (88.1%)

10 (11.9%)

84

Estrogen receptor

Positive

85 (69.1%)

38 (30.9%)

123

0.80

Negative

32 (71.1%)

13 (28.9%)

45

Progesterone receptor

Positive

66 (70.2%)

28 (29.8%)

94

0.96

Negative

44 (69.8%)

19 (30.2%)

63

HER2

Positive

14 (53.8%)

12 (46.2%)

26

0.036

Negative

98 (74.2%)

34 (25.8%)

132

Molecular subtypes

Luminal A-like

30 (88.2%)

4 (11.8%)

34

0.006

Luminal B-like

39 (65.0%)

21 (35.0%)

60

HER2-positive

14 (53.8%)

12 (46.2%)

26

Triple negative

23 (85.2%)

4 (14.8%)

27

  1. Abbreviations: ER Estrogen receptor; PgR Progesterone receptor